| Year |
Citation |
Score |
| 2020 |
Kunos CA, Rubinstein LV, Capala J, McDonald MA. Phase 0 Radiopharmaceutical-Agent Clinical Development. Frontiers in Oncology. 10: 1310. PMID 33014772 DOI: 10.3389/Fonc.2020.01310 |
0.36 |
|
| 2020 |
Small W, Bosch WR, Harkenrider MM, Strauss JB, Abu-Rustum N, Albuquerque KV, Beriwal S, Creutzberg CL, Eifel PJ, Erickson BA, Fyles AW, Hentz CL, Jhingran A, Klopp AH, Kunos CA, et al. NRG Oncology /RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer- An Update. International Journal of Radiation Oncology, Biology, Physics. PMID 32905846 DOI: 10.1016/J.Ijrobp.2020.08.061 |
0.313 |
|
| 2020 |
Kunos CA, Abdallah R. Financial Toxicity Encountered in Therapeutic Radiopharmaceutical Clinical Development for Ovarian Cancer. Pharmaceuticals (Basel, Switzerland). 13. PMID 32764223 DOI: 10.3390/Ph13080181 |
0.42 |
|
| 2020 |
Myint ZW, Kunos CA. Bone Fracture Incidence After Androgen Deprivation Therapy-Investigational Agents: Results From Cancer Therapy Evaluation Program-Sponsored Early Phase Clinical Trials 2006-2013. Frontiers in Oncology. 10: 1125. PMID 32760670 DOI: 10.3389/Fonc.2020.01125 |
0.346 |
|
| 2020 |
Chauhan A, Kabir T, Wu J, Wei J, Cook M, Kunos CA. Prognostic and predictive factors associated with ipilimumab-related adverse events: a retrospective analysis of 11 NCI-sponsored phase I clinical trials. Oncotarget. 11: 1427-1434. PMID 32363000 DOI: 10.18632/Oncotarget.27537 |
0.318 |
|
| 2020 |
Kunos C, Ferris G, Waggoner S. Implementing chemoradiation treatment for patients with cervical cancer in a comprehensive cancer center community oncology practice. Community Oncology. 7: 446-450. PMID 31723339 |
0.373 |
|
| 2020 |
Biswas T, Dowlati A, Kunos C, Pink J, Oleinick N, Malik SM, Fu P, Bruno DS, Bajor DL, Patel M, Machtay M. Base excision repair (BER) inhibitor TRC 102 (Methoxyamine) combined with pemetrexed (PEM)-based chemo-radiation (CRT) for locally advanced non-squamous non-small cell lung cancer (NS-NSCLC): Results of a phase I trial. Journal of Clinical Oncology. 38: 9027-9027. DOI: 10.1200/Jco.2020.38.15_Suppl.9027 |
0.388 |
|
| 2020 |
Rychahou P, Chauhan A, Chow Z, Izumi T, Chen Q, Lee EY, Napier D, Anthony LB, Cavnar MJ, Kunos C, Evers BM. Abstract 6402: DNA-PK inhibitor, M3814, as a radiation sensitizer in the treatment of neuroendocrine tumors Cancer Research. 80: 6402-6402. DOI: 10.1158/1538-7445.Am2020-6402 |
0.372 |
|
| 2019 |
Kunos CA, Andrews SJ, Moore KN, Chon HS, Ivy SP. Randomized Phase II Trial of Triapine-Cisplatin-Radiotherapy for Locally Advanced Stage Uterine Cervix or Vaginal Cancers. Frontiers in Oncology. 9: 1067. PMID 31681600 DOI: 10.3389/Fonc.2019.01067 |
0.438 |
|
| 2019 |
Kunos CA, Capala J, Dicker AP, Movsas B, Ivy SP, Minasian LM. Clinical Outcome Assessments Toolbox for Radiopharmaceuticals. Frontiers in Oncology. 9: 1028. PMID 31649885 DOI: 10.3389/Fonc.2019.01028 |
0.331 |
|
| 2019 |
Ivy SP, Kunos CA, Arnaldez FI, Kohn EC. Defining and targeting wild-type BRCA high-grade serous ovarian cancer: DNA repair and cell cycle checkpoints. Expert Opinion On Investigational Drugs. 28: 771-785. PMID 31449760 DOI: 10.1080/13543784.2019.1657403 |
0.375 |
|
| 2019 |
Kinsella TJ, Safran H, Wiersma SR, DiPetrillo T, Schumacher A, Rosati K, Vatkevich J, Anderson LW, Hill K, Kunos CA, Collins JM. Phase I and Pharmacology study of Ropidoxuridine (IPdR) as prodrug for iododeoxyuridine-mediated tumor radiosensitization in advanced GI cancer undergoing radiation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31337643 DOI: 10.1158/1078-0432.Ccr-19-0862 |
0.476 |
|
| 2019 |
Kunos CA, Capala J, Kohn EC, Ivy SP. Radiopharmaceuticals for Persistent or Recurrent Uterine Cervix Cancer. Frontiers in Oncology. 9: 560. PMID 31297338 DOI: 10.3389/Fonc.2019.00560 |
0.431 |
|
| 2019 |
Kunos CA, Ivy P. Leveraging National Cancer Institute Programmatic Collaboration for Uterine Cervix Cancer Brachytherapy in Puerto Rico After Hurricane Maria. Frontiers in Oncology. 9: 414. PMID 31157171 DOI: 10.3389/Fonc.2019.00414 |
0.379 |
|
| 2019 |
Kunos CA, Capala J, Finnigan S, Smith GL, Ivy SP. Radiopharmaceuticals for Relapsed or Refractory Ovarian Cancers. Frontiers in Oncology. 9: 180. PMID 30984615 DOI: 10.3389/Fonc.2019.00180 |
0.436 |
|
| 2019 |
Kunos CA, Capala J, Ivy SP. Radiopharmaceuticals for Relapsed or Refractory Leukemias. Frontiers in Oncology. 9: 97. PMID 30859091 DOI: 10.3389/Fonc.2019.00097 |
0.378 |
|
| 2019 |
Kizilbash SH, McBrayer S, Port J, Reid JM, Lanza I, Allred JB, Chakravarti A, Kunos C, Adjei AA. A phase Ib trial of CB-839 (telaglenastat) in combination with radiation therapy and temozolomide in patients with IDH-mutated diffuse astrocytoma and anaplastic astrocytoma (NCT03528642). Journal of Clinical Oncology. 37: TPS2075-TPS2075. DOI: 10.1200/Jco.2019.37.15_Suppl.Tps2075 |
0.382 |
|
| 2019 |
Chauhan A, Rychahou P, Izumi T, Arnold SM, Anthony LB, Evers M, Kunos C. Antitumor efficacy of M3814 as a radiation sensitizer in neuroendocrine tumor (NET) preclinical models. Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.E15699 |
0.343 |
|
| 2019 |
Kizilbash SH, Burgenske DM, McBrayer S, Devarajan S, Gupta SK, Hitosugi T, He L, Schroeder MA, Carlson BL, Gelman M, Kunos CA, Reid JM, Adjei AA, Sarkaria JN. Abstract 3870: The addition of CB-839 to temozolomide significantly reduces glioma aspartate and glutamate in an IDH mutated patient derived glioma xenograft model Cancer Research. 79: 3870-3870. DOI: 10.1158/1538-7445.Sabcs18-3870 |
0.319 |
|
| 2018 |
Kunos CA, Capala J. National Cancer Institute Programmatic Collaboration for Investigational Radiopharmaceuticals. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 488-494. PMID 30231365 DOI: 10.1200/EDBK_200199 |
0.302 |
|
| 2018 |
Boardman CH, Brady WE, Dizon DS, Kunos CA, Moore KN, Zanotti KM, Matthews C, Cosin JA, Aghajanian C, Fracasso PM. A Phase I Evaluation of Extended Field Radiation Therapy With Concomitant Cisplatin Chemotherapy Followed by Paclitaxel and Carboplatin Chemotherapy in Women With Cervical Carcinoma Metastatic to the Para-aortic Lymph Nodes: An NRG Oncology/Gynecologic Oncology Group Study. Gynecologic Oncology. PMID 30174176 DOI: 10.1016/J.Ygyno.2018.08.006 |
0.41 |
|
| 2018 |
Kunos CA, Ivy SP. Triapine Radiochemotherapy in Advanced Stage Cervical Cancer. Frontiers in Oncology. 8: 149. PMID 29868473 DOI: 10.3389/Fonc.2018.00149 |
0.487 |
|
| 2018 |
Kunos CA, Massett HA, Galassi A, Walker JL, Good MJ, Díaz LB, McCaskill-Stevens W. Leveraging National Cancer Institute Programmatic Collaboration for Uterine Cervix Cancer Patient Accrual in Puerto Rico. Frontiers in Oncology. 8: 102. PMID 29692980 DOI: 10.3389/Fonc.2018.00102 |
0.403 |
|
| 2018 |
Marciscano AE, Walker JM, McGee HM, Kim MM, Kunos CA, Monjazeb AM, Shiao SL, Tran PT, Ahmed MM. Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop. Journal For Immunotherapy of Cancer. 6: 6. PMID 29375032 DOI: 10.1186/S40425-018-0317-Y |
0.359 |
|
| 2018 |
Kunos CA, Coleman CN. Current and Future Initiatives for Radiation Oncology at the National Cancer Institute in the Era of Precision Medicine. International Journal of Radiation Oncology, Biology, Physics. PMID 29325810 DOI: 10.1016/J.Ijrobp.2017.02.225 |
0.412 |
|
| 2017 |
Kunos CA, Kohn EC. Editorial: New Approaches to Radiation-Therapeutic Agent Cancer Care for Women. Frontiers in Oncology. 7: 276. PMID 29473016 DOI: 10.3389/Fonc.2017.00276 |
0.374 |
|
| 2017 |
Kunos CA, Chu E, Makower D, Kaubisch A, Sznol M, Ivy SP. Phase I Trial of Triapine-Cisplatin-Paclitaxel Chemotherapy for Advanced Stage or Metastatic Solid Tumor Cancers. Frontiers in Oncology. 7: 62. PMID 28421163 DOI: 10.3389/Fonc.2017.00062 |
0.391 |
|
| 2016 |
Kunos CA. Commentary: Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer. Frontiers in Oncology. 6: 263. PMID 28066719 DOI: 10.3389/fonc.2016.00263 |
0.312 |
|
| 2015 |
Kunos CA, Olszewski S, Espinal E. Impact of nurse navigation on timeliness of diagnostic medical services in patients with newly diagnosed lung cancer. The Journal of Community and Supportive Oncology. 13: 219-24. PMID 26270521 DOI: 10.12788/Jcso.0141 |
0.301 |
|
| 2015 |
Kunos CA, Fabien JM, Shanahan JP, Collen C, Gevaert T, Poels K, Van den Begin R, Engels B, De Ridder M. Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy. Journal of Visualized Experiments : Jove. e52875. PMID 26131774 DOI: 10.3791/52875 |
0.408 |
|
| 2015 |
Kunos CA, Sherertz TM, Mislmani M, Ellis RJ, Lo SS, Waggoner SE, Zanotti KM, Herrmann K, Debernardo RL. Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer. Frontiers in Oncology. 5: 126. PMID 26097831 DOI: 10.3389/Fonc.2015.00126 |
0.435 |
|
| 2015 |
Kunos C, Deng W, Dawson D, Lea JS, Zanotti KM, Gray HJ, Bender DP, Guaglianone PP, Carter JS, Moore KN. A phase I-II evaluation of veliparib (NSC #737664), topotecan, and filgrastim or pegfilgrastim in the treatment of persistent or recurrent carcinoma of the uterine cervix: an NRG Oncology/Gynecologic Oncology Group study. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 25: 484-92. PMID 25594147 DOI: 10.1097/Igc.0000000000000380 |
0.431 |
|
| 2015 |
Kunos CA, Shanahan JP. 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Definition of Lung Targets in Vero Stereotactic Body Radiation Therapy Workflow Journal of Nuclear Medicine and Radiation Therapy. 6. DOI: 10.4172/2155-9619.1000227 |
0.314 |
|
| 2014 |
Viswanathan AN, Erickson B, Gaffney DK, Beriwal S, Bhatia SK, Lee Burnett O, D'Souza DP, Patil N, Haddock MG, Jhingran A, Jones EL, Kunos CA, Lee LJ, Lin LL, Mayr NA, et al. Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer. International Journal of Radiation Oncology, Biology, Physics. 90: 320-8. PMID 25304792 DOI: 10.1016/J.Ijrobp.2014.06.005 |
0.328 |
|
| 2014 |
Kunos CA, Sherertz TM. Long-Term Disease Control with Triapine-Based Radiochemotherapy for Patients with Stage IB2-IIIB Cervical Cancer. Frontiers in Oncology. 4: 184. PMID 25105092 DOI: 10.3389/Fonc.2014.00184 |
0.419 |
|
| 2014 |
Mislmani M, Frasure H, Suppiah S, Fabien J, Lo SS, Debernardo R, Kunos CA. Acute gastrointestinal toxicity after robotic stereotactic ablative radiotherapy for treatment of metastatic gynecological malignancies. Future Oncology (London, England). 10: 241-8. PMID 24490610 DOI: 10.2217/Fon.13.215 |
0.382 |
|
| 2014 |
Olsen JR, Moughan J, Myerson RJ, Abitbol A, Kunos C, Johnson D, Schefter T, Chen Y, Fisher BJ, Michalski JM, Narayan S, Chang A, Crane CH, Kachnic LA. Predictors of radiotherapy-related gastrointestinal toxicity from anal cancer DP-IMRT: Secondary analysis of RTOG 0529. Journal of Clinical Oncology. 32: 460-460. DOI: 10.1200/Jco.2014.32.3_Suppl.460 |
0.417 |
|
| 2014 |
Mislmani M, Sherertz TM, Waggoner S, Zanotti K, Resnick K, Lo SS, Ellis RJ, Machtay M, DeBernardo R, Kunos C. Concurrent Carboplatin and Gemcitabine With SBRT for Persistent or Recurrent Gynecological Cancers: A Phase 1 Trial International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.716 |
0.353 |
|
| 2014 |
Olsen JR, Moughan J, Myerson RJ, Abitbol AA, Kunos C, Johnson DW, Schefter T, Chen Y, Fisher B, Michalski J, Narayan S, Chang AJ, Crane CH, Kachnic LA. Predictors of Radiotherapy-Related GI Toxicity from Anal Cancer DP-IMRT: Secondary Analysis of RTOG 0529 International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.138 |
0.416 |
|
| 2013 |
Weinberg LE, Kunos CA, Zanotti KM. Lymphovascular space invasion (LVSI) is an isolated poor prognostic factor for recurrence and survival among women with intermediate- to high-risk early-stage endometrioid endometrial cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 23: 1438-45. PMID 24257558 DOI: 10.1097/Igc.0B013E3182A16C93 |
0.322 |
|
| 2013 |
Kunos CA, Stefan T, Jacobberger JW. Cabazitaxel-induced stabilization of microtubules enhances radiosensitivity in ovarian cancer cells. Frontiers in Oncology. 3: 226. PMID 24066277 DOI: 10.3389/Fonc.2013.00226 |
0.387 |
|
| 2013 |
Kunos CA, Spelic M. Role of stereotactic radiosurgery in gynecologic cancer. Current Opinion in Oncology. 25: 532-8. PMID 23942297 DOI: 10.1097/CCO.0b013e328363e0ad |
0.344 |
|
| 2013 |
Kunos CA, Radivoyevitch T, Waggoner S, Debernardo R, Zanotti K, Resnick K, Fusco N, Adams R, Redline R, Faulhaber P, Dowlati A. Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers. Gynecologic Oncology. 130: 75-80. PMID 23603372 DOI: 10.1016/J.Ygyno.2013.04.019 |
0.422 |
|
| 2013 |
Berber B, Sanabria JR, Braun K, Yao M, Ellis RJ, Kunos CA, Sohn J, Machtay M, Teh BS, Huang Z, Mayr NA, Lo SS. Emerging role of stereotactic body radiotherapy in the treatment of pancreatic cancer. Expert Review of Anticancer Therapy. 13: 481-7. PMID 23560842 DOI: 10.1586/Era.13.19 |
0.465 |
|
| 2013 |
Kunos CA, Winter K, Dicker AP, Small W, Abdul-Karim FW, Dawson D, Jhingran A, Valicenti R, Weidhaas JB, Gaffney DK. Ribonucleotide reductase expression in cervical cancer: a radiation therapy oncology group translational science analysis. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 23: 615-21. PMID 23552804 DOI: 10.1097/Igc.0B013E31828B4Eb5 |
0.402 |
|
| 2013 |
Shunkwiler L, Ferris G, Kunos C. Inhibition of Poly(ADP-Ribose) Polymerase Enhances Radiochemosensitivity in Cancers Proficient in DNA Double-Strand Break Repair International Journal of Molecular Sciences. 14: 3773-3785. PMID 23396107 DOI: 10.3390/Ijms14023773 |
0.404 |
|
| 2013 |
Simpkins F, Papadia A, Kunos C, Michener C, Frasure H, AbuShahin F, Mariani A, Bakkum-Gamez JN, Landrum L, Moore K, Thomas SG, Windhorn A, Rose PG. Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 23: 98-104. PMID 23221731 DOI: 10.1097/Igc.0B013E318276D9B6 |
0.435 |
|
| 2013 |
Weinberg L, Kunos C, Zanotti K. Lymphadenectomy in women with early-stage intermediate-to high-risk endometrial cancer (HIR-EC) decreases local recurrence but not overall recurrence or survival: A retrospective cohort study Gynecologic Oncology. 130. DOI: 10.1016/J.Ygyno.2013.04.223 |
0.375 |
|
| 2013 |
Kunos C, Brindle J, Singh S, Pettigrew G, DeBernardo R. Phase II trial of robotic cyberknife radiation therapy in patients with recurrent gynecological malignancies Gynecologic Oncology. 130. DOI: 10.1016/J.Ygyno.2013.04.079 |
0.373 |
|
| 2013 |
Mislmani M, Suppiah S, Frasure H, Lo S, Debernardo R, Kunos C. Gastrointestinal Toxicity After Robotic Stereotactic Ablative Radiation Therapy (SABR) for Treatment of Metastatic Gynecologic Malignancies International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.1122 |
0.362 |
|
| 2012 |
Kunos CA, Brindle J, Waggoner S, Zanotti K, Resnick K, Fusco N, Adams R, Debernardo R. Phase II Clinical Trial of Robotic Stereotactic Body Radiosurgery for Metastatic Gynecologic Malignancies. Frontiers in Oncology. 2: 181. PMID 23227452 DOI: 10.3389/Fonc.2012.00181 |
0.375 |
|
| 2012 |
Kunos CA, Radivoyevitch T, Kresak A, Dawson D, Jacobberger J, Yang B, Abdul-Karim FW. Elevated ribonucleotide reductase levels associate with suppressed radiochemotherapy response in human cervical cancers. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 22: 1463-9. PMID 23051959 DOI: 10.1097/Igc.0B013E318270577F |
0.409 |
|
| 2012 |
Kunos CA. Therapeutic Mechanisms of Treatment in Cervical and Vaginal Cancer. Oncology & Hematology Review. 8: 55-60. PMID 22943045 |
0.302 |
|
| 2012 |
Kunos C, Brindle JM, Debernardo R. Stereotactic radiosurgery for gynecologic cancer. Journal of Visualized Experiments : Jove. PMID 22546879 DOI: 10.3791/3793 |
0.441 |
|
| 2012 |
Kunos C, Radivoyevitch T, Abdul-Karim FW, Fanning J, Abulafia O, Bonebrake AJ, Usha L. Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study. Journal of Translational Medicine. 10: 79. PMID 22541066 DOI: 10.1186/1479-5876-10-79 |
0.335 |
|
| 2012 |
Choe J, Kulasekere R, Oddo D, Anthony S, Shin T, Murray M, Kunos CA. Helical tomotherapy versus conventional radiation to deliver abdominopelvic radiation. Technology in Cancer Research & Treatment. 11: 49-56. PMID 22181331 DOI: 10.7785/Tcrt.2012.500234 |
0.461 |
|
| 2012 |
Chao J, Synold TW, Morgan RJ, Kunos C, Longmate J, Lenz HJ, Lim D, Shibata S, Chung V, Stoller RG, Belani CP, Gandara DR, McNamara M, Gitlitz BJ, Lau DH, et al. A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study. Cancer Chemotherapy and Pharmacology. 69: 835-43. PMID 22105720 DOI: 10.1007/S00280-011-1779-5 |
0.389 |
|
| 2012 |
Goyal K, Einstein D, Ibarra RA, Yao M, Kunos C, Ellis R, Brindle J, Singh D, Hardacre J, Zhang Y, Fabians J, Funkhouser G, Machtay M, Sanabria JR. Stereotactic body radiation therapy for nonresectable tumors of the pancreas. The Journal of Surgical Research. 174: 319-25. PMID 21937061 DOI: 10.1016/J.Jss.2011.07.044 |
0.381 |
|
| 2012 |
Kunos C, Brindle J, Adams R, DeBernardo R. Phase II trial of robotic stereotactic radiosurgery (SBRT) in patients with recurrent gynecologic malignancies. Journal of Clinical Oncology. 30: 5102-5102. DOI: 10.1200/Jco.2012.30.15_Suppl.5102 |
0.435 |
|
| 2012 |
Weinberg LE, Zanotti KM, Kunos C. Association of smoking with pulmonary recurrences among women with intermediate- to high-risk early-stage endometrial adenocarcinoma. Journal of Clinical Oncology. 30: 5089-5089. DOI: 10.1200/Jco.2012.30.15_Suppl.5089 |
0.331 |
|
| 2012 |
Kunos C, Winter K, Dicker A, Small W, Abdul-Karim F, Dawson D, Jhingran A, Valicenti R, Weidhaas J, Gaffney D. RTOG 0116 and 0128: Secondary analysis of ribonucleotide reductase in cervix cancer Gynecologic Oncology. 125. DOI: 10.1016/J.Ygyno.2011.12.104 |
0.366 |
|
| 2012 |
Ellis RJ, Patel RB, Kunos C, Zhang Y, Brindle J, Kudithipudi V, Kaminsky DA, Ponsky L. Stereotactic Radiosurgery for Renal Cancer: Phase I Safety and Toxicity International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.209 |
0.342 |
|
| 2012 |
Siddiqui F, Kunos CA, Paulino AC. Stereotactic body radiation therapy in head and neck, gynecologic, and pediatric malignancies Journal of Radiation Oncology. 1: 31-42. DOI: 10.1007/S13566-012-0009-Z |
0.428 |
|
| 2011 |
Kunos C, Waggoner SE, Zanotti KM, DeBernardo R, Fusco N, Heugel A, Knazek J, Adams R, Radivoyevitch T, Dowlati A. Phase II trial of pelvic radiation, weekly cisplatin, and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) for locally advanced cervical and vaginal cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 5034. PMID 28023711 DOI: 10.1200/Jco.2011.29.15_Suppl.5034 |
0.439 |
|
| 2011 |
Kunos CA, Debernardo R, Fabien J, Dobbins DC, Zhang Y, Brindle J, Faulhaber PF. (18)FDG-PET/CT Definition of Clinical Target Volume for Robotic Stereotactic Body Radiosurgery Treatment of Metastatic Gynecologic Malignancies. Journal of Nuclear Medicine & Radiation Therapy. PMID 25506042 DOI: 10.4172/2155-9619.S4-001 |
0.315 |
|
| 2011 |
Kunos CA, Radivoyevitch T. Molecular Strategies of Deoxynucleotide Triphosphate Supply Inhibition Used in the Treatment of Gynecologic Malignancies. Gynecology & Obstetrics (Sunnyvale, Calif.). 001. PMID 25392744 DOI: 10.4172/2161-0932.S4-001 |
0.353 |
|
| 2011 |
Schwandt A, Chen WC, Martra F, Zola P, Debernardo R, Kunos CA. Chemotherapy plus radiation in advanced-stage endometrial cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 21: 1622-7. PMID 21897269 DOI: 10.1097/Igc.0B013E31822B6594 |
0.452 |
|
| 2011 |
Mayr NA, Huang Z, Sohn JW, Lo SS, Teh BS, Lu JJ, Grecula JC, Kunos C. Emerging application of stereotactic body radiation therapy for gynecologic malignancies. Expert Review of Anticancer Therapy. 11: 1069-75. PMID 21806330 DOI: 10.1586/Era.11.81 |
0.469 |
|
| 2011 |
Kunos C, Radivoyevitch T, Abdul-Karim FW, Faulhaber P. 18F-fluoro-2-deoxy-D-glucose positron emission tomography standard uptake value ratio as an indicator of cervical cancer chemoradiation therapeutic response. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 21: 1117-23. PMID 21792015 DOI: 10.1097/Igc.0B013E31821Dc8B5 |
0.302 |
|
| 2011 |
Kunos CA, Ferris G, Pyatka N, Pink J, Radivoyevitch T. Deoxynucleoside salvage facilitates DNA repair during ribonucleotide reductase blockade in human cervical cancers. Radiation Research. 176: 425-33. PMID 21756082 DOI: 10.1667/Rr2556.1 |
0.326 |
|
| 2011 |
Kunos CA, Colussi VC, Pink J, Radivoyevitch T, Oleinick NL. Radiosensitization of human cervical cancer cells by inhibiting ribonucleotide reductase: enhanced radiation response at low-dose rates. International Journal of Radiation Oncology, Biology, Physics. 80: 1198-204. PMID 21470790 DOI: 10.1016/J.Ijrobp.2011.01.034 |
0.409 |
|
| 2011 |
Kunos C, Woods C, Colussi VC, Abdul-Karim FW, Waggoner S. Low-dose-rate brachytherapy for treatment of uterine didelphys malignancy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e104-6. PMID 21098325 DOI: 10.1200/Jco.2010.31.7545 |
0.316 |
|
| 2011 |
Kunos CA, Sill MW, Buekers TE, Walker JL, Schilder JM, Yamada SD, Waggoner SE, Mohiuddin M, Fracasso PM. Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: a phase I study of the Gynecologic Oncology Group. Gynecologic Oncology. 120: 224-8. PMID 21075438 DOI: 10.1016/J.Ygyno.2010.10.018 |
0.454 |
|
| 2011 |
Friedman LC, Abdallah R, Schluchter M, Panneerselvam A, Kunos CA. Adherence to vaginal dilation following high dose rate brachytherapy for endometrial cancer. International Journal of Radiation Oncology, Biology, Physics. 80: 751-7. PMID 20619551 DOI: 10.1016/J.Ijrobp.2010.02.058 |
0.389 |
|
| 2011 |
Zheng Y, Zhang Y, Brindle J, Fabien J, Chen W, Woods C, Galanopoulos N, Choe J, Kunos C, Ellis RJ, Ponsky LEMC, Funkhouser G, Machtay M, Einstein D, Wessels BW. SU‐E‐T‐644: Software Tool Used in Setting Optimization Control Points for Hypofractionated CyberKnife Treatment Planning Medical Physics. 38: 3638-3638. DOI: 10.1118/1.3612607 |
0.376 |
|
| 2010 |
Kunos CA, Radivoyevitch T, Pink J, Chiu SM, Stefan T, Jacobberger J, Kinsella TJ. Ribonucleotide reductase inhibition enhances chemoradiosensitivity of human cervical cancers. Radiation Research. 174: 574-81. PMID 20954859 DOI: 10.1667/Rr2273.1 |
0.359 |
|
| 2010 |
Goyal K, Einstein D, Yao M, Kunos C, Barton F, Singh D, Siegel C, Stulberg J, Sanabria J. Cyberknife stereotactic body radiation therapy for nonresectable tumors of the liver: preliminary results. Hpb Surgery : a World Journal of Hepatic, Pancreatic and Biliary Surgery. 2010. PMID 20689733 DOI: 10.1155/2010/309780 |
0.365 |
|
| 2010 |
Kunos C, Ali S, Abdul-Karim FW, Stehman FB, Waggoner S. Posttherapy residual disease associates with long-term survival after chemoradiation for bulky stage 1B cervical carcinoma: a Gynecologic Oncology Group study. American Journal of Obstetrics and Gynecology. 203: 351.e1-8. PMID 20541170 DOI: 10.1016/J.Ajog.2010.05.005 |
0.396 |
|
| 2010 |
Kunos CA, Waggoner S, von Gruenigen V, Eldermire E, Pink J, Dowlati A, Kinsella TJ. Phase I trial of pelvic radiation, weekly cisplatin, and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) for locally advanced cervical cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 1298-306. PMID 20145183 DOI: 10.1158/1078-0432.Ccr-09-2469 |
0.427 |
|
| 2010 |
Rasool N, Fader AN, Seamon L, Neubauer NL, Shahin FA, Alexander HA, Moore K, Moxley K, Secord AA, Kunos C, Rose PG, O'Malley DM. Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrence. Gynecologic Oncology. 116: 10-4. PMID 19875158 DOI: 10.1016/J.Ygyno.2009.10.043 |
0.359 |
|
| 2010 |
Kunos C, Ferris G, Waggoner S. Implementing chemoradiation treatment for patients with cervical cancer in a comprehensive cancer center community oncology practice. Community Oncology. 7: 446-450. DOI: 10.1016/S1548-5315(11)70424-7 |
0.469 |
|
| 2009 |
Kunos CA, Chiu SM, Pink J, Kinsella TJ. Modulating radiation resistance by inhibiting ribonucleotide reductase in cancers with virally or mutationally silenced p53 protein. Radiation Research. 172: 666-76. PMID 19929413 DOI: 10.1667/Rr1858.1 |
0.411 |
|
| 2009 |
Kunos C, Tian C, Waggoner S, Rose PG, Lanciano R. Retrospective analysis of concomitant Cisplatin during radiation in patients aged 55 years or older for treatment of advanced cervical cancer: a gynecologic oncology group study. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 19: 1258-63. PMID 19823064 DOI: 10.1111/Igc.0B013E3181B33Ace |
0.393 |
|
| 2009 |
Kunos C, Chen W, DeBernardo R, Waggoner S, Brindle J, Zhang Y, Williams J, Einstein D. Stereotactic Body Radiosurgery for Pelvic Relapse of Gynecologic Malignancies Technology in Cancer Research & Treatment. 8: 393-400. PMID 19754216 DOI: 10.1177/153303460900800510 |
0.44 |
|
| 2009 |
Kunos C, Simpkins F, Gibbons H, Tian C, Homesley H. Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial. Obstetrics and Gynecology. 114: 537-46. PMID 19701032 DOI: 10.1097/Aog.0B013E3181B12F99 |
0.421 |
|
| 2009 |
Goksedef BPC, Kunos C, Belinson JL, Rose PG. Concurrent cisplatin-based chemoradiation International Federation of Gynecology and Obstetrics stage IB2 cervical carcinoma. American Journal of Obstetrics and Gynecology. 200: 175-177. PMID 19091305 DOI: 10.1016/J.Ajog.2008.08.055 |
0.393 |
|
| 2009 |
Choe J, Kulasekere R, Oddo D, Anthony S, Shin T, Kunos C. Novel Method for Delivering Highly Conformal Whole Abdominal Irradiation with Helical Tomotherapy International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.864 |
0.421 |
|
| 2008 |
Zagar TM, Shenk RR, Kim JA, Harpp D, Kunos CA, Abdul-Karim FW, Chen WC, Seo Y, Kinsella TJ. Radiation therapy in addition to gross total resection of retroperitoneal sarcoma results in prolonged survival: results from a single institutional study. Journal of Oncology. 2008: 824036. PMID 19277103 DOI: 10.1155/2008/824036 |
0.42 |
|
| 2008 |
Kunos C, Gibbons H, Simpkins F, Waggoner S. Chemotherapy Administration during Pelvic Radiation for Cervical Cancer Patients Aged >/=55 Years in the SEER-Medicare Population. Journal of Oncology. 2008: 931532-931532. PMID 19259335 DOI: 10.1155/2008/931532 |
0.412 |
|
| 2008 |
Kunos C, von Gruenigen V, Waggoner S, Brindle J, Zhang Y, Myers B, Funkhouser G, Wessels B, Einstein D. Cyberknife radiosurgery for squamous cell carcinoma of vulva after prior pelvic radiation therapy. Technology in Cancer Research & Treatment. 7: 375-80. PMID 18783287 DOI: 10.1177/153303460800700504 |
0.463 |
|
| 2008 |
Kunos CA, Dobbins DC, Kulasekere R, Latimer B, Kinsella TJ. Comparison of helical tomotherapy versus conventional radiation to deliver craniospinal radiation. Technology in Cancer Research & Treatment. 7: 227-33. PMID 18473494 DOI: 10.1177/153303460800700308 |
0.614 |
|
| 2008 |
Martra F, Kunos C, Gibbons H, Zola P, Galletto L, DeBernardo R, Gruenigen Vv. Adjuvant treatment and survival in obese women with endometrial cancer: an international collaborative study. American Journal of Obstetrics and Gynecology. 198: 89-91. PMID 18166317 DOI: 10.1016/J.Ajog.2007.06.023 |
0.362 |
|
| 2008 |
Simpkins F, Kunos C, Mariani A, Bakkum-Gamez J, Landrum L, Moore K, Michener C, Rose PG. Impact of adjuvant radiation therapy (RT) on recurrence and survival outcomes in stage IB-IIA endometrial cancer (EMCA) patients with lymph vascular invasion (LVSI) Journal of Clinical Oncology. 26: 5568-5568. DOI: 10.1200/Jco.2008.26.15_Suppl.5568 |
0.401 |
|
| 2008 |
Goksedef BP, Kunos C, Belinson J, Rose PG. Concurrent cisplatin-based chemoradiation for figo stage 1b2 cervical carcinoma Journal of Clinical Oncology. 26: 16595-16595. DOI: 10.1200/Jco.2008.26.15_Suppl.16595 |
0.414 |
|
| 2006 |
Kunos C, Latson L, Overmoyer B, Silverman P, Shenk R, Kinsella T, Lyons J. Breast Conservation Surgery Achieving ≥ 2 mm Tumor-Free Margins Results in Decreased Local-Regional Recurrence Rates Breast Journal. 12: 28-36. PMID 16409584 DOI: 10.1111/J.1075-122X.2006.00181.X |
0.354 |
|
| 2006 |
Kunos C, Martra F, Frasure H, Zola P, Waggoner S, Gruenigen Vv. 2359 : Retrospective Comparison of Surgical and Radiation Treatment in Early Stage Endometrial Cancer in the United States and Italy International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.768 |
0.401 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2012 |
Kunos CA, Debernardo R, Radivoyevitch T, Fabien J, Dobbins DC, Zhang Y, Brindle J. Hematological toxicity after robotic stereotactic body radiosurgery for treatment of metastatic gynecologic malignancies. International Journal of Radiation Oncology, Biology, Physics. 84: e35-41. PMID 22543208 DOI: 10.1016/J.Ijrobp.2012.02.027 |
0.3 |
|
| 2021 |
Biswas T, Dowlati A, Kunos CA, Pink JJ, Oleinick NL, Malik S, Fu P, Cao S, Bruno DS, Bajor DL, Patel M, Gerson SL, Machtay M. Adding Base Excision Repair Inhibitor TRC102 to standard Pemetrexed-Platinum-Radiation in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer: Results of a phase I trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34740922 DOI: 10.1158/1078-0432.CCR-21-2025 |
0.295 |
|
| 2020 |
Kunos CA, Capala J. Radiopharmaceutical Switch Maintenance for Relapsed Ovarian Carcinoma. Pharmaceuticals (Basel, Switzerland). 13. PMID 33008086 DOI: 10.3390/ph13100287 |
0.295 |
|
| 2016 |
Takebe N, Ahmed MM, Vikram B, Bernhard EJ, Zwiebel J, Norman Coleman C, Kunos CA. Radiation-Therapeutic Agent Clinical Trials: Leveraging Advantages of a National Cancer Institute Programmatic Collaboration. Seminars in Radiation Oncology. 26: 271-80. PMID 27619249 DOI: 10.1016/j.semradonc.2016.06.005 |
0.292 |
|
| 2006 |
Kunos C, Colussi V, Getty P, Kinsella T. Intraoperative electron radiotherapy for extremity sarcomas does not increase acute or late morbidity. Clinical Orthopaedics and Related Research. 446: 247-252. PMID 16467624 DOI: 10.1097/01.Blo.0000203470.43184.8C |
0.291 |
|
| 2019 |
Chauhan A, Kabir T, Wu J, Wei J, Kunos C. Prognostic and predictive factors associated with ipilimumab related adverse events: A retrospective analysis of 11 NCI sponsored ipilimumab phase I clinical trials. Journal of Clinical Oncology. 37: 86-86. DOI: 10.1200/Jco.2019.37.8_Suppl.86 |
0.285 |
|
| 2020 |
Teicher BA, Doyle A, Wright J, Kunos C, Silvers T, Delosh R, Laudeman J, Reinhart R, Ogle C, Coussens N, Morris J, Doroshow J. Abstract 328: DNA damage inhibitors with topotecan in a complex spheroid model in PDM and established cell lines Cancer Research. 80: 328-328. DOI: 10.1158/1538-7445.Am2020-328 |
0.284 |
|
| 2023 |
Kunos CA, Piekarz R, Collins JM, Kinsella TJ. A case report of typhlitis during novel use of ropidoxuridine-capecitabine-radiotherapy for treatment-naïve rectal cancer. Cancer Chemotherapy and Pharmacology. PMID 37369852 DOI: 10.1007/s00280-023-04561-4 |
0.282 |
|
| 2019 |
Kunos CA, Capala J, Ivy SP. Leveraging National Cancer Institute Programmatic Collaboration for Single Radiopharmaceutical Drug Master Files. Frontiers in Oncology. 9: 573. PMID 31316916 DOI: 10.3389/Fonc.2019.00573 |
0.282 |
|
| 2012 |
Weinberg L, Kunos C, Zanotti K. Lymphovascular space invasion is an isolated poor prognostic factor for recurrence among women with intermediate to high-risk early stage endometrioid endometrial adenocarcinoma of the uterus Gynecologic Oncology. 125. DOI: 10.1016/J.Ygyno.2011.12.384 |
0.281 |
|
| 2021 |
Lheureux S, Cristea MC, Bruce JP, Garg S, Cabanero M, Mantia-Smaldone G, Olawaiye AB, Ellard SL, Weberpals JI, Wahner Hendrickson AE, Fleming GF, Welch S, Dhani NC, Stockley T, Rath P, ... ... Kunos CA, et al. Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet (London, England). 397: 281-292. PMID 33485453 DOI: 10.1016/S0140-6736(20)32554-X |
0.279 |
|
| 2010 |
Choe J, Chen W, Woods C, Wessels B, Zheng Y, Brindle J, Zhang Y, Kunos C, Lyons J, Einstein D. Toxicity Data For Hypofractionated Radiosurgery Using the Linear Quadratic Model to Constrain Normal Organ Tolerance Doses International Journal of Radiation Oncology Biology Physics. 78. DOI: 10.1016/J.Ijrobp.2010.07.348 |
0.278 |
|
| 2020 |
Kunos CA. Novel Radiosensitization Strategies in Uterine Cervix Cancer. Seminars in Radiation Oncology. 30: 281-290. PMID 32828384 DOI: 10.1016/j.semradonc.2020.05.001 |
0.276 |
|
| 2023 |
Kunos CA, Fabian D, Fredericks T, Baldwin L, Dietrich C, Miller RW, Ueland FR. Hemoglobin level associates with survival in women from Appalachian Kentucky with uterine cervix cancer. Frontiers in Oncology. 13: 1132135. PMID 37483504 DOI: 10.3389/fonc.2023.1132135 |
0.274 |
|
| 2011 |
Debernardo R, Starks D, Barker N, Armstrong A, Kunos CA. Robotic surgery in gynecologic oncology. Obstetrics and Gynecology International. 2011: 139867. PMID 22190946 DOI: 10.1155/2011/139867 |
0.269 |
|
| 2011 |
Rojas D, Snyder L, Ibarra RA, Singh D, Yao M, Kunos C, Aucejo FN, Siegel C, Milano MT, Katz A, Goodman KA, Stephans K, El-Gazzaz G, Miller CM, Fung JJ, et al. Multicenter Results of Stereotactic Body Radiotherapy (SBRT) for Secondary Tumors of the Liver Gastroenterology. 140. DOI: 10.1016/S0016-5085(11)64374-6 |
0.266 |
|
| 2021 |
Kunos CA, Howells R, Chauhan A, Myint ZW, Bernard ME, El Khouli R, Capala J. Radiopharmaceutical Validation for Clinical Use. Frontiers in Oncology. 11: 630827. PMID 33747951 DOI: 10.3389/fonc.2021.630827 |
0.266 |
|
| 2015 |
Feng Y, Kunos CA, Xu Y. Determination of triapine, a ribonucleotide reductase inhibitor, in human plasma by liquid chromatography tandem mass spectrometry. Biomedical Chromatography : Bmc. PMID 25677991 DOI: 10.1002/Bmc.3434 |
0.265 |
|
| 2006 |
Kunos C, Schupp J, Kinsella T. 2333 International Journal of Radiation Oncology*Biology*Physics. 66: S395-S396. DOI: 10.1016/J.Ijrobp.2006.07.741 |
0.264 |
|
| 2014 |
Kunos CA. Novel biological radiochemotherapy approaches in locally advanced-stage cervical cancer management. Discovery Medicine. 17: 179-86. PMID 24759622 |
0.261 |
|
| 2017 |
Matsumoto J, Kiesel BF, Parise RA, Guo J, Taylor S, Huang M, Eiseman JL, Ivy SP, Kunos C, Chu E, Beumer JH. LC-MS/MS assay for the quantitation of the ribonucleotide reductase inhibitor triapine in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 146: 154-160. PMID 28881312 DOI: 10.1016/J.Jpba.2017.08.036 |
0.261 |
|
| 2020 |
Roncali E, Capala J, Benedict SH, Akabani G, Bednarz B, Bhadrasain V, Bolch WE, Buchsbaum J, Clarke BN, Coleman N, Dewaraja YK, Frey EC, Ghaly M, Grudzinski J, Hobbs RF, ... ... Kunos C, et al. Overview of the First NRG-NCI Workshop on Dosimetry of Systemic Radiopharmaceutical Therapy (RPT). Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 33277396 DOI: 10.2967/jnumed.120.255547 |
0.251 |
|
| 2020 |
Jabbour SK, Williams TM, Sayan M, Miller ED, Ajani JA, Chang AC, Coleman N, El-Rifai W, Haddock M, Ilson D, Jamorabo D, Kunos C, Lin S, Liu G, Prasanna PG, et al. Potential Molecular Targets in the Setting of Chemoradiation for Esophageal Malignancies. Journal of the National Cancer Institute. PMID 33351071 DOI: 10.1093/jnci/djaa195 |
0.249 |
|
| 2021 |
Kunos CA, Fabian D, Kudrimoti M, Miller RW, Ueland FR, Randall ME. Characterization of Uterine Cervix Cancers in Women from Appalachian Kentucky. Frontiers in Oncology. 11: 808081. PMID 34956914 DOI: 10.3389/fonc.2021.808081 |
0.247 |
|
| 2014 |
Kunos CA, Abdallah RR, Lyons JA. Hydration during breast radiotherapy may lower skin toxicity. The Breast Journal. 20: 679-81. PMID 25252223 DOI: 10.1111/Tbj.12348 |
0.246 |
|
| 2007 |
Zheng Y, Syh J, Greskovich JF, Kunos C, Wessels BW. SU‐FF‐I‐59: A Machine Independent Threshold Method for PET Target Delineation Medical Physics. 34: 2351-2351. DOI: 10.1118/1.2760436 |
0.245 |
|
| 2001 |
Edelson G, Kunos CA, Vigder F, Obed E. Bony changes at the lateral epicondyle of possible significance in tennis elbow syndrome Journal of Shoulder and Elbow Surgery. 10: 158-163. PMID 11307080 DOI: 10.1067/Mse.2001.112020 |
0.241 |
|
| 2021 |
Kunos CA, Mankoff DA, Schultz MK, Graves SA, Pryma DA. Radiopharmaceutical Chemistry and Drug Development-What's Changed? Seminars in Radiation Oncology. 31: 3-11. PMID 33246634 DOI: 10.1016/j.semradonc.2020.07.006 |
0.239 |
|
| 2017 |
Kunos CA, Galanis E, Buchsbaum J, Shi Q, Strauss LC, Coleman CN, Ahmed MM. Radiation-agent combinations for glioblastoma: challenges in drug development and future considerations. Journal of Neuro-Oncology. PMID 28560665 DOI: 10.1007/s11060-017-2458-0 |
0.238 |
|
| 2024 |
Kunos CA, Martin ME, Georgiou MF, Kuker RA, Chauhan A. Leveraging Programmatic Collaboration for a Radiopharmaceutical Clinic. Cancers. 16. PMID 38611074 DOI: 10.3390/cancers16071396 |
0.233 |
|
| 2023 |
Gonzalez-Ochoa E, Milosevic M, Corr B, Abbruzzese JL, Girda E, Miller RW, Croke J, Mackay H, Lee YC, Bowering V, Ramsahai J, Wang L, D'Souza A, Kunos CA, Oza AM, et al. A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 37380217 DOI: 10.1136/ijgc-2023-004491 |
0.232 |
|
| 2023 |
Kunos CA, Fabian D, Napier D, Stonecypher MS, Duncan RM, Hurt J. Human gastrin- releasing peptide receptor expression in women with uterine cervix cancer. Frontiers in Oncology. 13: 1126426. PMID 36761980 DOI: 10.3389/fonc.2023.1126426 |
0.227 |
|
| 2016 |
Kunos CA, Chu E, Beumer JH, Sznol M, Ivy SP. Phase I trial of daily triapine in combination with cisplatin chemotherapy for advanced-stage malignancies. Cancer Chemotherapy and Pharmacology. PMID 27878356 DOI: 10.1007/s00280-016-3200-x |
0.226 |
|
| 2023 |
Kunos CA, Lemieux BP, Recca K, Oates ME, El Khouli RH. Leveraging Radiopharmaceutical Programmatic Collaboration for Management of Pretherapy and On-treatment Urinary Incontinence. Health Physics. 125: 316-319. PMID 37548565 DOI: 10.1097/HP.0000000000001721 |
0.223 |
|
| 2012 |
Kunos CA, Radivoyevitch T, Ingalls ST, Hoppel CL. Management of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone-induced methemoglobinemia. Future Oncology (London, England). 8: 145-50. PMID 22335579 DOI: 10.2217/Fon.11.147 |
0.223 |
|
| 2015 |
Ferris GJ, Shunkwiler LB, Kunos CA. Two-step procedure for evaluating experimentally induced DNA damage: Texas Red and Comet assays. Methods in Molecular Biology (Clifton, N.J.). 1249: 183-91. PMID 25348306 DOI: 10.1007/978-1-4939-2013-6_13 |
0.222 |
|
| 2004 |
Kunos CA, Resnick MI, Kinsella TJ, Ellis RJ. Migration of implanted free radioactive seeds for adenocarcinoma of the prostate using a Mick applicator. Brachytherapy. 3: 71-7. PMID 15374538 DOI: 10.1016/J.Brachy.2004.06.002 |
0.216 |
|
| 2023 |
Ladbury C, Sueyoshi MH, Brovold NM, Kumar R, Andraos TY, Gogineni E, Kim M, Klopp A, Albuquerque K, Kunos C, Leung E, Mantz C, Biswas T, Beriwal S, Small W, et al. Stereotactic Body Radiation Therapy for Gynecologic Malignancies: A Case-Based Radiosurgery Society Practice Review. Practical Radiation Oncology. PMID 37875223 DOI: 10.1016/j.prro.2023.09.008 |
0.214 |
|
| 2022 |
Rimel BJ, Kunos CA, Macioce N, Temkin SM. Current gaps and opportunities in screening, prevention, and treatment of cervical cancer. Cancer. PMID 36239009 DOI: 10.1002/cncr.34487 |
0.211 |
|
| 2021 |
Hong JA, Brechbiel M, Buchsbaum J, Canaria CA, Coleman CN, Escorcia FE, Espey M, Kunos C, Lin F, Narayanan D, Capala J. National Cancer Institute support for targeted alpha-emitter therapy. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34378064 DOI: 10.1007/s00259-021-05503-z |
0.21 |
|
| 2022 |
Rodriguez CP, Kang H, Geiger JL, Burtness B, Chung CH, Pickering CR, Fakhry C, Le QT, Yom SS, Galloway TJ, Golemis E, Li A, Shoop J, Wong S, Mehra R, ... ... Kunos C, et al. Clinical Trial Development in TP53-Mutated Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Journal of the National Cancer Institute. PMID 36053203 DOI: 10.1093/jnci/djac163 |
0.206 |
|
| 2020 |
Kabir TF, Kunos CA, Villano JL, Chauhan A. Immunotherapy for Medulloblastoma: Current Perspectives. Immunotargets and Therapy. 9: 57-77. PMID 32368525 DOI: 10.2147/ITT.S198162 |
0.202 |
|
| 2012 |
Radivoyevitch T, Saunthararajah Y, Pink J, Ferris G, Lent I, Jackson M, Junk D, Kunos CA. dNTP Supply Gene Expression Patterns after P53 Loss. Cancers. 4: 1212-24. PMID 23205301 DOI: 10.3390/Cancers4041212 |
0.199 |
|
| 1999 |
Kunos CA, Simpson SW, Russell KF, Hershkovitz I. First rib metamorphosis: Its possible utility for human age-at-death estimation American Journal of Physical Anthropology. 110: 303-323. PMID 10516563 DOI: 10.1002/(Sici)1096-8644(199911)110:3<303::Aid-Ajpa4>3.0.Co;2-O |
0.196 |
|
| 2012 |
Radivoyevitch T, Kunos CA. On model ensemble analyses of nonmonotonic data. Nucleosides, Nucleotides & Nucleic Acids. 31: 147-56. PMID 22303993 DOI: 10.1080/15257770.2011.644370 |
0.191 |
|
| 2019 |
Foster JC, Freidlin B, Kunos CA, Korn EL. Single-Arm Phase II Trials of Combination Therapies: A Review of the CTEP Experience 2008-2017. Journal of the National Cancer Institute. PMID 31545373 DOI: 10.1093/jnci/djz193 |
0.181 |
|
| 2022 |
Myint ZW, El Khouli R, Lemieux B, Yan D, St Clair WH, Liu X, Kunos CA. A single arm phase II study of bone-targeted Sn-117 m-DTPA in symptomatic castration-resistant prostate cancer with skeletal metastases. Bmc Cancer. 22: 415. PMID 35428207 DOI: 10.1186/s12885-022-09496-2 |
0.167 |
|
| 2020 |
Riess JW, Frankel P, Shackelford D, Dunphy M, Badawi RD, Nardo L, Cherry SR, Lanza I, Reid J, Gonsalves WI, Kunos C, Gandara DR, Lara PN, Newman E, Paik PK. Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Patients With Advanced NSCLC (NCI 10327): Rationale and Study Design. Clinical Lung Cancer. PMID 33229301 DOI: 10.1016/j.cllc.2020.10.006 |
0.155 |
|
| 2013 |
Kunos CA, Petersen IA. Radiation quality, like art, consists in drawing the line somewhere. Frontiers in Oncology. 3: 163. PMID 23882449 DOI: 10.3389/fonc.2013.00163 |
0.15 |
|
| 2020 |
Capala J, Kunos CA. A new generation of "magic bullets" for molecular targeting of cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33144340 DOI: 10.1158/1078-0432.CCR-20-3690 |
0.134 |
|
| 2020 |
Sohn JW, Kim H, Park SB, Lee S, Monroe JI, Malone TB, Kinsella T, Yao M, Kunos C, Lo SS, Shenk R, Machtay M. Clinical Study of Using Biometrics to Identify Patient and Procedure. Frontiers in Oncology. 10: 586232. PMID 33335855 DOI: 10.3389/fonc.2020.586232 |
0.129 |
|
| 2020 |
Joshi A, Kiesel BF, Chaphekar N, Jones R, Guo J, Kunos CA, Taylor S, Chu E, Venkataramanan R, Beumer JH. In vitro evaluation of the metabolic enzymes and drug interaction potential of triapine. Cancer Chemotherapy and Pharmacology. PMID 32989483 DOI: 10.1007/s00280-020-04154-5 |
0.126 |
|
| 2023 |
Kunos CA, Fabian D, Piecoro DW, Napier D, Miller RW, Ueland FR. Human epidermal growth factor receptor 2 expression in women with uterine cervix adenocarcinoma from Appalachian Kentucky. Frontiers in Oncology. 13: 948348. PMID 36761943 DOI: 10.3389/fonc.2023.948348 |
0.081 |
|
| 1998 |
Simpson SW, Kunos CA. A radiographic study of the development of the human mandibular dentition Journal of Human Evolution. 35: 479-505. PMID 9774507 DOI: 10.1006/jhev.1998.0235 |
0.072 |
|
| Hide low-probability matches. |